Clinical Trial Update: Reduction of Cardiovascular Risk in Severe Mental Illness [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring reduction of cardiovascular risk in individuals with severe mental illness, including schizophrenia and bipolar disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Consorci Hospitalari de Vic | Conditions: Severe Mental Illness, Schizophrenia | Phase 4 | Status: UNKNOWN